We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

94 hedge funds and large institutions have $639M invested in Epizyme, Inc in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,498% more call options, than puts

Call options by funds: $783K | Put options by funds: $49K

110% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 10

13% more funds holding

Funds holding: 83 → 94 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

9% less capital invested

Capital invested by funds: $699M → $639M (-$60.1M)

Holders
94
Holders Change
+11
Holders Change %
+13.25%
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
29
Reduced
29
Closed
10
Calls
$783K
Puts
$49K
Net Calls
+$734K
Net Calls Change
+$311K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$16.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.3M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$12.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.56M
5
PA
Perceptive Advisors
New York
+$7.5M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$40.3M
2
BA
BlackRock Advisors
Delaware
-$12.7M
3
DCM
Driehaus Capital Management
Illinois
-$2.58M
4
Axa
Axa
France
-$2.27M
5
SFM
Sphera Funds Management
Israel
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
26
BlackRock Institutional Trust
California
$3.62M -$271K -8,723 -6%
RSCM
27
Rock Springs Capital Management
Maryland
$3.55M +$4.07M +131,000 New
QBFM
28
QS Batterymarch Financial Management
New York
$2.78M -$292K -9,400 -8%
Adage Capital Partners
29
Adage Capital Partners
Massachusetts
$2.71M +$3.11M +100,000 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$2.41M +$432K +13,897 +19%
Principal Financial Group
31
Principal Financial Group
Iowa
$1.97M -$37.3K -1,200 -2%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.63M +$284K +9,122 +18%
Morgan Stanley
33
Morgan Stanley
New York
$1.59M +$1.27M +40,711 +229%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$1.56M +$1.06M +34,011 +145%
SFM
35
Sphera Funds Management
Israel
$1.36M -$1.96M -63,188 -56%
Millennium Management
36
Millennium Management
New York
$1.32M -$466K -15,009 -24%
TCIM
37
TIAA CREF Investment Management
New York
$1.31M – – –
CS
38
Credit Suisse
Switzerland
$1.25M +$1.12M +36,141 +367%
BIM
39
BlackRock Investment Management
Delaware
$959K -$617K -19,851 -36%
Deutsche Bank
40
Deutsche Bank
Germany
$900K -$315K -10,137 -23%
Charles Schwab
41
Charles Schwab
California
$765K +$17.3K +556 +2%
Marshall Wace
42
Marshall Wace
United Kingdom
$706K +$546K +17,577 +207%
CCMH
43
Cornerstone Capital Management Holdings
New York
$661K +$758K +24,400 New
FSA
44
Franklin Street Advisors
North Carolina
$625K -$157K -5,050 -18%
ProShare Advisors
45
ProShare Advisors
Maryland
$607K -$124K -3,979 -15%
PP
46
PDT Partners
New York
$586K +$672K +21,620 New
Macquarie Group
47
Macquarie Group
Australia
$542K – – –
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$534K +$21.8K +700 +4%
TA
49
Teachers Advisors
New York
$492K – – –
HTHT
50
Hemenway Trust Hemenway Trust
New Hampshire
$488K -$404K -13,000 -42%
1
2
3 4 5

EPZM Hedge Fund Activity: Q3 2014 in Review

94 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2014, worth a combined $639M — down 8.6% from $699M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new EPZM positions and 10 closed out — a net gain of 11 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was State Street, adding an estimated $16.8M. The largest seller was NEA Management Company, cutting an estimated $40.3M.

  • 94 institutional investors held Epizyme, Inc (EPZM) as of Q3 2014, up from 83 in Q2 2014.
  • Funds reported $639M of Epizyme, Inc stock for Q3 2014, down 8.6% quarter-over-quarter.
  • 21 funds opened new Epizyme, Inc positions in Q3 2014 and 10 closed out, a net change of +11 holders.
  • The largest Epizyme, Inc buyer in Q3 2014 was State Street, an estimated $16.8M added.
  • The largest Epizyme, Inc seller in Q3 2014 was NEA Management Company, an estimated $40.3M sold.

Based on aggregated 13F filings for Q3 2014.